Globalisation and the growing efforts to standardise
submission requirements and formats internationally
continue to open up new markets for life sciences
companies. Yet, there are still significant differences in
requirements between regions and individual nations. With
this in mind, Kimty Bui-Van of ProductLife Group assesses
current regulatory climates in four markets with strategic
appeal: Benelux, the Baltics, Canada, and South Africa.